Cytochrome P450 CYP2C9 gene variants have been associated with hyperresponsiveness
to small doses of warfarin and a higher bleeding complication rate. The aim of this study was …

Study objectives To investigate whether the FIIA 20210 mutation is associated with isolated
pulmonaryembolism (PE). Design Case-control study. Setting Five thrombosis centers in …

Objective. To assess the role of nitrite (NO 2 − ), nitrate (NO 3 − ), and nitrative stress in
thrombotic primary antiphospholipid syndrome (PAPS). Methods. We investigated 46 patients …

Patients carrying the FV Leiden or the FII A 20210 mutation have a high risk of venous
thromboembolism. Among 542 patients with a documented diagnosis of deep venous thrombosis …

Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence
in Italy of 2% of the total population. The recent spreadout of the COVID-19 pandemic …

Background Patients with primary antiphospholipid syndrome (PAPS) may suffer from venous
and/or arterial thrombosis, but studies addressing eventual clinical and laboratory features …

The aimof this studay was to compare bleeding and re-thrombosis in primary antiphospholipid
syndrome (PAPS), mitral valve replacement (MVR) and inherited thrombophilia (IT) at …

Background. The prevalence of heart failure with preserved ejection fraction (HFpEF) in
patients with antiphospholipid syndrome (APS) is unknown. Methods. A prospective multicenter …

Background The proprotein convertase subtilisin/kexin type 9 (PCSK9) is emerging as a
novel cardiovascular risk factor. Levels of PCSK9 in thrombotic primary antiphospholipid …

Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence
in Italy of 2% of the total population. About a quarter of the anticoagulated patients require …